Man Group
RVMD icon

Man Group’s Revolution Medicines RVMD Stock Holding History

Man Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.8M Buy
275,270
+177,765
+182% +$18M 0.05% 390
2025
Q4 		$7.77M Buy
97,505
+91,511
+1,527% +$6M 0.01% 898
2025
Q3 		$280K Sell
5,994
-18,179
-75% -$712K ﹤0.01% 2028
2025
Q2 		$889K Sell
24,173
-49,685
-67% -$1.91M ﹤0.01% 1660
2025
Q1 		$2.61M Sell
73,858
-247,815
-77% -$10.1M 0.01% 1255
2024
Q4 		$14.1M Buy
321,673
+65,567
+26% +$3.31M 0.04% 590
2024
Q3 		$11.6M Sell
256,106
-26,640
-9% -$1.16M 0.03% 662
2024
Q2 		$11M Buy
282,746
+253,449
+865% +$9.47M 0.03% 668
2024
Q1 		$944K Buy
+29,297
New +$868K ﹤0.01% 1563

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Man Group's RVMD Position: Q1 2026 in Review

Man Group increased its Revolution Medicines (RVMD) stake by 182% in Q1 2026, buying an estimated $18M and bringing the position to 275,270 shares worth $26.8M. The position accounts for 0.05% of the portfolio, ranked #390.

Man Group first reported a position in RVMD in Q1 2024 and has held it in 9 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Man Group held 275,270 shares of Revolution Medicines worth $26.8M as of Q1 2026.
  • Man Group bought 177,765 Revolution Medicines shares in Q1 2026, an estimated $18M.
  • Revolution Medicines made up 0.05% of Man Group's portfolio in Q1 2026, its #390 holding.
  • Man Group first reported a position in Revolution Medicines in Q1 2024 and has held it in 9 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.